Corcept Therapeutics Incorporated logo
Corcept Therapeutics Incorporated CORT
$ 56.36 0.48%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Corcept Therapeutics Incorporated Balance Sheet 2011-2024 | CORT

Annual Balance Sheet Corcept Therapeutics Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - -27.8 M -41.6 M -31.1 M -36.9 M -25.5 M -14.8 M -49.1 M -90.4 M -39.6 M

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

151 K 1.14 M 526 K 2.05 M 1.56 M - - 14.7 M 15 M 9.42 M 5.74 M 2.65 M -

Total Non Current Liabilities

- - - - 2.29 M 239 K - - 12.6 M 24.5 M 29.3 M 29 M -

Total Current Liabilities

105 M 72.5 M 47.5 M 47.5 M 38.8 M 35.6 M 29.6 M 27.4 M 20.9 M 13.6 M 12.7 M 8.36 M 5.03 M

Total Liabilities

115 M 81.6 M 48 M 48.4 M 41.1 M 35.8 M 29.6 M 27.4 M 33.4 M 38 M 42.1 M 37.4 M 5.03 M

Deferred Revenue

- - - - - - - - 158 K 33 K 25 K 16 K -

Retained Earnings

403 M 296 M 195 M 82.5 M -23.6 M -118 M -193 M -322 M -330 M -324 M -293 M -247 M -209 M

Total Assets

622 M 583 M 424 M 572 M 412 M 312 M 221 M 68.8 M 51.9 M 34.6 M 63.1 M 99.2 M 39.8 M

Cash and Cash Equivalents

136 M 66.3 M 77.6 M 76.2 M 31.3 M 41.6 M 31.1 M 51.5 M 40.4 M 24.2 M 54.9 M 93 M 39.6 M

Book Value

507 M 502 M 376 M 523 M 371 M 276 M 191 M 41.4 M 18.5 M -3.39 M 21 M 61.8 M 34.8 M

Total Shareholders Equity

507 M 502 M 376 M 523 M 371 M 276 M 191 M 41.4 M 18.5 M -3.39 M 21 M 61.8 M 34.8 M

All numbers in USD currency

Quarterly Balance Sheet Corcept Therapeutics Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

6.36 M 5.62 M - - - - - - - 552 K - - - - 501 K 501 K 501 K 501 K 1.9 M 1.9 M 1.9 M 1.9 M - - - - - - - - - - - - 12.5 M 12.5 M 12.5 M 12.5 M 24.5 M 24.5 M 24.5 M 24.5 M 29.3 M 29.3 M 29.3 M 29.3 M 29 M 29 M 29 M 29 M - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

145 M 118 M 108 M 132 M 103 M 88.3 M - 59.9 M - 60.3 M 48 M 45.2 M 45.8 M 41.6 M 48.4 M 48.4 M 48.4 M 48.4 M 41.1 M 41.1 M 41.1 M 41.1 M 35.8 M 35.8 M 35.8 M 35.8 M 29.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 158 K 158 K 158 K 158 K 33 K 33 K 33 K 33 K 25 K 25 K 25 K 25 K 16 K 16 K 16 K 16 K - - - -

Retained Earnings

513 M 466 M 430 M 371 M 340 M 312 M - 280 M - 218 M 195 M 163 M 132 M 106 M 82.5 M 82.5 M 82.5 M 82.5 M -23.6 M -23.6 M -23.6 M -23.6 M -118 M -118 M -118 M -118 M -193 M -193 M -193 M -193 M -322 M -322 M -322 M -322 M -330 M -330 M -330 M -330 M -324 M -324 M -324 M -324 M -293 M -293 M -293 M -293 M -247 M -247 M -247 M -247 M -209 M -199 M -192 M -

Total Assets

784 M 715 M 656 M 594 M 525 M 618 M - 533 M - 468 M 424 M 585 M 568 M 552 M 572 M 572 M 572 M 572 M 412 M 412 M 412 M 412 M 312 M 312 M 312 M 312 M 221 M 221 M 221 M 221 M 68.8 M 68.8 M 68.8 M 68.8 M 51.9 M 51.9 M 51.9 M 51.9 M 34.6 M 34.6 M 34.6 M 34.6 M 63.1 M 63.1 M 63.1 M 63.1 M 99.2 M 99.2 M 99.2 M 99.2 M 39.8 M 39.8 M 39.8 M 39.8 M

Cash and Cash Equivalents

137 M 129 M 150 M 112 M 172 M 300 M - 50.2 M 35.3 M 61.9 M 77.6 M 94.7 M 95.4 M 52.4 M 76.2 M 76.2 M 76.2 M 76.2 M 31.3 M 31.3 M 31.3 M 31.3 M 41.6 M 41.6 M 41.6 M 41.6 M 31.1 M 31.1 M 31.1 M 31.1 M 51.5 M 51.5 M 51.5 M 51.5 M 40.4 M 40.4 M 40.4 M 40.4 M 24.2 M 24.2 M 24.2 M 24.2 M 54.9 M 54.9 M 54.9 M 54.9 M 93 M 93 M 93 M 93 M 39.6 M 39.6 M 39.6 M 39.6 M

Book Value

639 M 596 M 548 M 462 M 422 M 530 M - 473 M - 408 M 376 M 540 M 523 M 511 M 523 M 523 M 523 M 523 M 371 M 371 M 371 M 371 M 276 M 276 M 276 M 276 M 191 M 221 M 221 M 221 M 68.8 M 68.8 M 68.8 M 68.8 M 51.9 M 51.9 M 51.9 M 51.9 M 34.6 M 34.6 M 34.6 M 34.6 M 63.1 M 63.1 M 63.1 M 63.1 M 99.2 M 99.2 M 99.2 M 99.2 M 39.8 M 39.8 M 39.8 M 39.8 M

Total Shareholders Equity

639 M 596 M 548 M 462 M 422 M 530 M - 473 M 442 M 408 M 376 M 540 M 523 M 511 M 523 M 523 M 523 M 523 M 371 M 371 M 371 M 371 M 276 M 276 M 276 M 276 M 191 M 191 M 191 M 191 M 41.4 M 41.4 M 41.4 M 41.4 M 18.5 M 18.5 M 18.5 M 18.5 M -3.39 M -3.39 M -3.39 M -3.39 M 21 M 21 M 21 M 21 M 61.8 M 61.8 M 61.8 M 61.8 M 34.8 M 34.8 M 34.8 M 34.8 M

All numbers in USD currency